- Active not recruitingPHASE1, PHASE2
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
This study looks at new drug combinations for advanced ER+ breast cancer in women aged 18-100. It tests LEE011 and BYL719 with letrozole to find safe and effective doses, hoping to improve treatment for this type of cancer.
For: Breast CancerUnited States · Australia · France - Active not recruitingPHASE2
Ribociclib (LEE011) Rollover Study for Continued Access
This study allows people already taking ribociclib (a cancer drug) in a Novartis trial to keep receiving it if it's helping them. It’s for those who have advanced cancer and are benefiting from the treatment.
For: Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesUnited States · France · Germany